Welcome to the Office of Cancer Survivorship Program, DCCPS
The NCI Office of Cancer Survivorship (OCS) works to enhance the quality and length of survival of all persons diagnosed with cancer and to prevent, minimize, or manage adverse effects of cancer and its treatment.
Stay up-to-date on everything from OCS @NCICancerSurv
Stay up-to-date on everything from DCCPS LinkedIn
Spotlight
Publication
In this recent publication in the Journal of Cancer Survivorship, Dr. Rachelle Brick and coauthors utilized data from the Cancer Support Community’s Cancer Experience Registry to describe the type and prevalence of survivorship concerns reported by individuals with metastatic cancer, and their associations with cancer diagnosis, treatment, and other variables. Read more.
Publication
In this recent publication in JNCI, Dr. Michelle Doose and coauthors examined the FY2017-22 NIH Cancer Survivorship Research Portfolio to determine whether survivorship research focused on populations experiencing health disparities has shifted from describing health disparities to a health equity research agenda that addresses structural drivers. Read more.
Upcoming Presentation
OCS New Investigators Series presents Building Partnerships to Sustain Your Program of Research
May 2024 – Register now for this upcoming OCS New Investigators Series webinar. On May 14, 2024, from 2-3 p.m. ET, Dr. Katie Devine will present Building Partnerships to Sustain Your Program of Research.
Upcoming Presentation
June 2024 – Join the NCI Office of Cancer Survivorship for this OCS Director’s Series webinar during National Cancer Survivors Month. On June 18, 2024, from 2-3:30 p.m. ET, OCS Director Dr. Emily Tonorezos will moderate Survivor Voices: The Vital Role of Survivors in Advancing Cancer Survivorship Research, featuring a panel of survivors, researchers, and advocates. Register now.
Funding Opportunities
About The Office of Cancer Survivorship
An individual is considered a cancer survivor from the time of diagnosis, through the balance of life. There are many types of survivors, including those living with cancer and those free of cancer. This term is meant to capture a population of those with a history of cancer rather than to provide a label that may or may not resonate with individuals.
OCS works to promote a better understanding of unique needs of the growing population of cancer survivors, and to enhance our ability to address them.
Quick Links
Featured Graph and Statistic
Individuals Living with Metastatic Cancer
Researchers at the National Cancer Institute have estimated that 623,405 people in the United States were living with metastatic breast, prostate, lung, colorectal, or bladder cancer or metastatic melanoma as of 2018, and that number is expected to increase to 693,452 by the year 2025.
Cancer Survivor Statistics
It is estimated that there are 18.1 million cancer survivors in the United States. This represents approximately 5.4% of the population.